Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	carbon-sulfur lyase activity	CENPVL2 CENPVL3 CENPVL1	5.94e-05	16	97	3	GO:0016846
GeneOntologyMolecularFunction	lyase activity	CBS MLYCD CRY2 CENPVL2 CENPVL3 ALOXE3 CENPVL1	7.88e-05	212	97	7	GO:0016829
GeneOntologyMolecularFunction	protein-arginine deiminase activity	PADI4 PADI3	2.31e-04	5	97	2	GO:0004668
GeneOntologyBiologicalProcess	DNA repair	MCM8 ANKLE1 TRIP13 FAAP100 RNF126 CDC45 FANCA CRY2 RUVBL1 PRPF19 BOD1L1 DOT1L VCP	9.49e-06	648	96	13	GO:0006281
Domain	KH_1	MEX3D MEX3C IGF2BP2 MEX3A AKAP1	1.35e-06	38	95	5	PF00013
Domain	-	MEX3D MEX3C IGF2BP2 MEX3A AKAP1	1.54e-06	39	95	5	3.30.1370.10
Domain	KH	MEX3D MEX3C IGF2BP2 MEX3A AKAP1	1.75e-06	40	95	5	SM00322
Domain	KH_dom	MEX3D MEX3C IGF2BP2 MEX3A AKAP1	1.75e-06	40	95	5	IPR004087
Domain	KH_TYPE_1	MEX3D MEX3C IGF2BP2 MEX3A AKAP1	2.24e-06	42	95	5	PS50084
Domain	KH_dom_type_1	MEX3D MEX3C IGF2BP2 MEX3A AKAP1	2.84e-06	44	95	5	IPR004088
Domain	Thioredoxin/glutathione_Rdtase	TXNRD1 TXNRD3	7.65e-05	3	95	2	IPR006338
Domain	Pyr_OxRdtase_I_AS	TXNRD1 TXNRD3	2.53e-04	5	95	2	IPR012999
Domain	Pyr_redox_dim	TXNRD1 TXNRD3	2.53e-04	5	95	2	PF02852
Domain	PAD	PADI4 PADI3	2.53e-04	5	95	2	PF03068
Domain	PAD_N	PADI4 PADI3	2.53e-04	5	95	2	PF08526
Domain	PAD_M	PADI4 PADI3	2.53e-04	5	95	2	PF08527
Domain	PAD	PADI4 PADI3	2.53e-04	5	95	2	IPR004303
Domain	PYRIDINE_REDOX_1	TXNRD1 TXNRD3	2.53e-04	5	95	2	PS00076
Domain	PAD_C	PADI4 PADI3	2.53e-04	5	95	2	IPR013530
Domain	Prot_Arg_deaminase_cen_dom	PADI4 PADI3	2.53e-04	5	95	2	IPR013733
Domain	PAD_N	PADI4 PADI3	2.53e-04	5	95	2	IPR013732
Domain	GLUTAREDOXIN_1	TXNRD1 TXNRD3	3.79e-04	6	95	2	PS00195
Domain	-	TXNRD1 TXNRD3	5.29e-04	7	95	2	3.30.390.30
Domain	Pyr_nucl-diS_OxRdtase_dimer	TXNRD1 TXNRD3	7.03e-04	8	95	2	IPR004099
Domain	FAD/NAD-linked_Rdtase_dimer	TXNRD1 TXNRD3	7.03e-04	8	95	2	IPR016156
Domain	A2M_N_2	A2M C5	7.03e-04	8	95	2	SM01359
Domain	-	A2M C5	7.03e-04	8	95	2	2.60.40.690
Domain	A2M_recep	A2M C5	7.03e-04	8	95	2	SM01361
Domain	A2M	A2M C5	7.03e-04	8	95	2	SM01360
Domain	Glutaredoxin	TXNRD1 TXNRD3	9.00e-04	9	95	2	PF00462
Domain	ZU5	ANK2 UNC5D	9.00e-04	9	95	2	SM00218
Domain	GLUTAREDOXIN_2	TXNRD1 TXNRD3	9.00e-04	9	95	2	PS51354
Domain	A2M	A2M C5	1.12e-03	10	95	2	PF00207
Domain	A2M_N_2	A2M C5	1.12e-03	10	95	2	IPR011625
Domain	A2M_comp	A2M C5	1.12e-03	10	95	2	IPR011626
Domain	A2M_recep	A2M C5	1.12e-03	10	95	2	PF07677
Domain	A2M_comp	A2M C5	1.12e-03	10	95	2	PF07678
Domain	Glutaredoxin	TXNRD1 TXNRD3	1.12e-03	10	95	2	IPR002109
Domain	A2M_N	A2M C5	1.12e-03	10	95	2	PF01835
Domain	A2M_N	A2M C5	1.12e-03	10	95	2	IPR002890
Domain	A-macroglobulin_rcpt-bd	A2M C5	1.12e-03	10	95	2	IPR009048
Domain	ALPHA_2_MACROGLOBULIN	A2M C5	1.12e-03	10	95	2	PS00477
Domain	ZU5	ANK2 UNC5D	1.12e-03	10	95	2	PS51145
Domain	A2M_N_2	A2M C5	1.12e-03	10	95	2	PF07703
Domain	Macroglobln_a2	A2M C5	1.12e-03	10	95	2	IPR001599
Domain	ZU5	ANK2 UNC5D	1.63e-03	12	95	2	PF00791
Domain	ZU5_dom	ANK2 UNC5D	1.63e-03	12	95	2	IPR000906
Domain	-	A2M C5	1.63e-03	12	95	2	1.50.10.20
Domain	-	MRC1 F12	1.93e-03	13	95	2	2.10.10.10
Domain	FN_type2_col-bd	MRC1 F12	2.24e-03	14	95	2	IPR000562
Domain	FN2_2	MRC1 F12	2.24e-03	14	95	2	PS51092
Domain	FN2_1	MRC1 F12	2.24e-03	14	95	2	PS00023
Domain	fn2	MRC1 F12	2.24e-03	14	95	2	PF00040
Domain	FN2	MRC1 F12	2.24e-03	14	95	2	SM00059
Domain	AAA	TRIP13 RUVBL1 VCP	2.35e-03	52	95	3	PF00004
Domain	Sushi	PAPPA2 CSMD2 SEZ6L2	2.35e-03	52	95	3	PF00084
Domain	ATPase_AAA_core	TRIP13 RUVBL1 VCP	2.62e-03	54	95	3	IPR003959
Domain	CCP	PAPPA2 CSMD2 SEZ6L2	2.62e-03	54	95	3	SM00032
Domain	SUSHI	PAPPA2 CSMD2 SEZ6L2	2.91e-03	56	95	3	PS50923
Domain	CBS	IMPDH1 CBS	2.93e-03	16	95	2	SM00116
Domain	Sushi_SCR_CCP_dom	PAPPA2 CSMD2 SEZ6L2	3.06e-03	57	95	3	IPR000436
Domain	ZF_RING_1	VPS11 MEX3D RNF126 MEX3C MEX3A RNF38	3.71e-03	291	95	6	PS00518
Domain	LH2	LPL ALOXE3	3.71e-03	18	95	2	SM00308
Domain	Terpenoid_cyclase/PrenylTrfase	A2M C5	3.71e-03	18	95	2	IPR008930
Domain	WD40_repeat_dom	VPS11 WDR88 STRAP PRPF19 ELP2 WDR90	4.09e-03	297	95	6	IPR017986
Domain	Pyr_redox_2	TXNRD1 TXNRD3	4.14e-03	19	95	2	PF07992
Domain	ZF_RING_2	VPS11 MEX3D RNF126 MEX3C MEX3A RNF38	4.16e-03	298	95	6	PS50089
Domain	CBS_dom	IMPDH1 CBS	4.58e-03	20	95	2	IPR000644
Domain	CBS	IMPDH1 CBS	4.58e-03	20	95	2	PF00571
Domain	CBS	IMPDH1 CBS	4.58e-03	20	95	2	PS51371
Domain	RING	VPS11 MEX3D RNF126 MEX3C MEX3A RNF38	4.66e-03	305	95	6	SM00184
Domain	-	LPL ALOXE3	5.05e-03	21	95	2	2.60.60.20
Domain	PLAT	LPL ALOXE3	5.05e-03	21	95	2	PF01477
Domain	PLAT/LH2_dom	LPL ALOXE3	5.05e-03	21	95	2	IPR001024
Domain	PLAT	LPL ALOXE3	5.05e-03	21	95	2	PS50095
Domain	TIR	TLR7 IL18R1	5.05e-03	21	95	2	SM00255
Pubmed	Improving GENCODE reference gene annotation using a high-stringency proteogenomics workflow.	CENPVL2 CENPVL3 CENPVL1	5.01e-07	6	103	3	27250503
Pubmed	Identification and characterization of human Mex-3 proteins, a novel family of evolutionarily conserved RNA-binding proteins differentially localized to processing bodies.	MEX3D MEX3C MEX3A	5.01e-07	6	103	3	17267406
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	FRAS1 IMPDH1 MEX3D AKNA ANKLE1 MLXIP FAAP100 FANCA CELSR1 ARVCF KCNJ11 TXNRD3 WDR90 DOT1L SPEN	9.26e-07	1105	103	15	35748872
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	A2M RALGDS FRAS1 MCM8 GON4L CDC45 FANCA ARVCF MTIF2 LPL ELP2	3.76e-06	650	103	11	38777146
Pubmed	Interaction with 14-3-3 adaptors regulates the sorting of hMex-3B RNA-binding protein to distinct classes of RNA granules.	MEX3D MEX3C MEX3A	5.44e-06	12	103	3	18779327
Pubmed	Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.	IGF2BP2 KCNJ11 LPL	7.06e-06	13	103	3	17463246
Pubmed	Inflammatory myofibroblastic tumors of the lung carrying a chimeric A2M-ALK gene: report of 2 infantile cases and review of the differential diagnosis of infantile pulmonary lesions.	A2M ALK	8.69e-06	2	103	2	28705706
Pubmed	Tracking a CAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitor.	CAD ALK	8.69e-06	2	103	2	28368455
Pubmed	IGF2BP2 promotes glycolysis and hepatocellular carcinoma stemness by stabilizing CDC45 mRNA via m6A modification.	CDC45 IGF2BP2	8.69e-06	2	103	2	37985379
Pubmed	Association of cross-reactive antibodies targeting peptidyl-arginine deiminase 3 and 4 with rheumatoid arthritis-associated interstitial lung disease.	PADI4 PADI3	8.69e-06	2	103	2	24901704
Pubmed	CUG start codon generates thioredoxin/glutathione reductase isoforms in mouse testes.	TXNRD1 TXNRD3	8.69e-06	2	103	2	20018845
Pubmed	Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity.	VPS11 NEDD4L RNF126 MEX3C MEX3A	9.69e-06	95	103	5	29643511
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	CAD NEDD4L MEX3D POLR2B MEX3C MEX3A STRAP PRPF19	1.18e-05	358	103	8	32460013
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ANK2 CHD1 CBS PRUNE1 IGF2BP2 RUVBL1 STRAP PRPF19 BOD1L1 AKAP1 VCP TP53BP2	2.14e-05	934	103	12	33916271
Pubmed	CRY1-CBS binding regulates circadian clock function and metabolism.	CBS CRY2	2.60e-05	3	103	2	32383312
Pubmed	Selenoprotein oxidoreductase with specificity for thioredoxin and glutathione systems.	TXNRD1 TXNRD3	2.60e-05	3	103	2	11259642
Pubmed	The amount of citrullinated proteins in synovial tissue is related to serum anti-cyclic citrullinated peptide (anti-CCP) antibody levels.	PADI4 PADI3	2.60e-05	3	103	2	26255191
Pubmed	Calcium-sensing receptor ubiquitination and degradation mediated by the E3 ubiquitin ligase dorfin.	CASR VCP	2.60e-05	3	103	2	16513638
Pubmed	Chromosomal locations and gonadal dependence of genes that mediate resistance to ectromelia (mousepox) virus-induced mortality.	LPL C5	2.60e-05	3	103	2	2002550
Pubmed	Mannose receptor polyubiquitination regulates endosomal recruitment of p97 and cytosolic antigen translocation for cross-presentation.	MRC1 VCP	2.60e-05	3	103	2	21628571
Pubmed	Dual role of K ATP channel C-terminal motif in membrane targeting and metabolic regulation.	ANK2 KCNJ11	2.60e-05	3	103	2	19805355
Pubmed	Peptidylarginine Deiminase Isozyme-Specific PAD2, PAD3 and PAD4 Inhibitors Differentially Modulate Extracellular Vesicle Signatures and Cell Invasion in Two Glioblastoma Multiforme Cell Lines.	PADI4 PADI3	2.60e-05	3	103	2	32098295
Pubmed	Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductases.	TXNRD1 TXNRD3	2.60e-05	3	103	2	10455115
Pubmed	Identification of residues in alpha-macroglobulins important for binding to the alpha2-macroglobulin receptor/Low density lipoprotein receptor-related protein.	A2M LPL	2.60e-05	3	103	2	8662686
Pubmed	Association analysis of IGF2BP2, KCNJ11, and CDKAL1 polymorphisms with type 2 diabetes mellitus in a Moroccan population: a case-control study and meta-analysis.	IGF2BP2 KCNJ11	2.60e-05	3	103	2	24898818
Pubmed	An Ideal PPAR Response Element Bound to and Activated by PPARα.	MLYCD LPL ALOXE3	2.77e-05	20	103	3	26241474
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	FLNB MEX3D POLR2B MEX3C IGF2BP2 MEX3A STRAP ERI3 AKAP1 SPEN VCP	2.82e-05	807	103	11	22681889
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	CAD POLR2B PRUNE1 RUVBL1 STRAP BOD1L1 DOT1L SPEN TP53BP2	3.84e-05	549	103	9	38280479
Pubmed	Mammalian selenoprotein thioredoxin-glutathione reductase. Roles in disulfide bond formation and sperm maturation.	TXNRD1 TXNRD3	5.19e-05	4	103	2	15901730
Pubmed	Molecular cloning of cDNAs of mouse peptidylarginine deiminase type I, type III and type IV, and the expression pattern of type I in mouse.	PADI4 PADI3	5.19e-05	4	103	2	10092850
Pubmed	CDX2 regulation by the RNA-binding protein MEX3A: impact on intestinal differentiation and stemness.	MEX3C MEX3A	5.19e-05	4	103	2	23408853
Pubmed	Peptidylarginine deiminase 1-catalyzed histone citrullination is essential for early embryo development.	PADI4 PADI3	5.19e-05	4	103	2	27929094
Pubmed	Dynamics of DOT1L localization and H3K79 methylation during meiotic prophase I in mouse spermatocytes.	TRIP13 DOT1L	5.19e-05	4	103	2	24105599
Pubmed	Translational regulation of lipoprotein lipase in adipocytes: depletion of cellular protein kinase Calpha activates binding of the C subunit of protein kinase A to the 3'-untranslated region of the lipoprotein lipase mRNA.	LPL AKAP1	5.19e-05	4	103	2	18387001
Pubmed	Role of the mannose receptor in phagocytosis of Enterococcus faecalis strain EC-12 by antigen-presenting cells.	MRC1 TLR7	5.19e-05	4	103	2	23801521
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	FLNB ANK2 CSMD2 FANCA KIF13A SPEN TP53BP2	5.80e-05	329	103	7	17474147
Pubmed	Maternal genes and facial clefts in offspring: a comprehensive search for genetic associations in two population-based cleft studies from Scandinavia.	FLNB FRAS1 CASR GDF1 CBS ARVCF LPL	6.02e-05	331	103	7	20634891
Pubmed	High-sensitivity profiling of SARS-CoV-2 noncoding region-host protein interactome reveals the potential regulatory role of negative-sense viral RNA.	POLR2B CBS IGF2BP2 MEX3A RUVBL1 STRAP PRPF19 VCP	8.00e-05	469	103	8	37314180
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	CAD IMPDH1 POLR2B TRIP13 MEX3C IGF2BP2 RUVBL1 PPP6C ARVCF PRPF19 DOT1L VCP TP53BP2	8.18e-05	1247	103	13	27684187
Pubmed	Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development.	PADI4 C5	8.64e-05	5	103	2	28223279
Pubmed	Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins.	CAD POLR2B RUVBL1 STRAP PRPF19 VCP	9.09e-05	244	103	6	29884807
Pubmed	Proteomic analysis identifies novel binding partners of BAP1.	CAD POLR2B RUVBL1 VCP	9.65e-05	80	103	4	34591877
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	FLNB CAD POLR2B TRIP13 CBS RUVBL1 STRAP PRPF19 VCP	1.21e-04	638	103	9	33239621
Pubmed	FANCA and FANCC modulate TLR and p38 MAPK-dependent expression of IL-1β in macrophages.	TLR7 FANCA	1.29e-04	6	103	2	24046015
Pubmed	FANCM of the Fanconi anemia core complex is required for both monoubiquitination and DNA repair.	FAAP100 FANCA	1.29e-04	6	103	2	18285517
Pubmed	Ankyrin-B regulates Kir6.2 membrane expression and function in heart.	ANK2 KCNJ11	1.29e-04	6	103	2	20610380
Pubmed	Effect of six candidate genes on early aging in a French population.	CBS LPL	1.29e-04	6	103	2	12889841
Pubmed	Comparative analysis of the mouse and human peptidylarginine deiminase gene clusters reveals highly conserved non-coding segments and a new human gene, PADI6.	PADI4 PADI3	1.29e-04	6	103	2	15087120
Pubmed	Reelin receptors ApoER2 and VLDLR are expressed in distinct spatiotemporal patterns in developing mouse cerebral cortex.	RELN UNC5D	1.29e-04	6	103	2	25308109
Pubmed	LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition.	MEX3D IQCN FAAP100 MEX3C MEX3A	1.48e-04	168	103	5	30631154
Pubmed	Identification of erythroid-enriched gene expression in the mouse embryonic yolk sac using microdissected cells.	RELN PF4	1.81e-04	7	103	2	18213587
Pubmed	Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population.	IGF2BP2 KCNJ11	1.81e-04	7	103	2	18162508
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	FLNB CAD POLR2B CHD1 TRIP13 CDC45 IGF2BP2 RUVBL1 PPP6C ARVCF PRPF19 VCP TP53BP2	1.83e-04	1353	103	13	29467282
Pubmed	Genes expressed in Atoh1 neuronal lineages arising from the r1/isthmus rhombic lip.	RELN AKNA CDC45 UNC5D	1.88e-04	95	103	4	21440680
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	A2M IMPDH1 NEDD4L ANK2 MEX3C IGF2BP2 RUVBL1 PPP6C STRAP PRPF19 C5 ALK VCP	2.08e-04	1371	103	13	36244648
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ZNF536 FRAS1 NEDD4L GON4L MLXIP BOD1L1 SPEN	2.16e-04	407	103	7	12693553
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	FLNB CAD NEDD4L POLR2B CHD1 TRIP13 IGF2BP2 RUVBL1 PRPF19 SPEN VCP	2.31e-04	1024	103	11	24711643
Pubmed	14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking.	FLNB NEDD4L CBS TXNRD1 RUVBL1	2.38e-04	186	103	5	14744259
Pubmed	Improvements in glucose homeostasis in response to regular exercise are influenced by the PPARG Pro12Ala variant: results from the HERITAGE Family Study.	IGF2BP2 KCNJ11	2.40e-04	8	103	2	20043145
Pubmed	Genetic variant in the IGF2BP2 gene may interact with fetal malnutrition to affect glucose metabolism.	IGF2BP2 KCNJ11	2.40e-04	8	103	2	19258437
Pubmed	Ndfip1 expression in developing neurons indicates a role for protein ubiquitination by Nedd4 E3 ligases during cortical development.	RELN NEDD4L	2.40e-04	8	103	2	24036464
Pubmed	Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening.	IGF2BP2 KCNJ11	2.40e-04	8	103	2	19033397
Pubmed	The longitudinal association of common susceptibility variants for type 2 diabetes and obesity with fasting glucose level and BMI.	IGF2BP2 KCNJ11	2.40e-04	8	103	2	20929593
Pubmed	The VCP-UBXN1 Complex Mediates Triage of Ubiquitylated Cytosolic Proteins Bound to the BAG6 Complex.	RNF126 VCP	2.40e-04	8	103	2	29685906
Pubmed	Impact of common variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2, and CDKAL1 on the risk of type 2 diabetes in 5,164 Indians.	IGF2BP2 KCNJ11	2.40e-04	8	103	2	20424228
Pubmed	Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease.	CAD CDC45 RUVBL1 PPP6C STRAP ERI3 VCP	2.54e-04	418	103	7	32552912
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	NEDD4L MCM8 MEX3D POLR2B MLXIP DENND4C MEX3C CRY2 RUVBL1 PPP6C STRAP	2.59e-04	1038	103	11	26673895
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	FLNB CAD POLR2B DUOX2 CHD1 TRIP13 CBS CDC45 RUVBL1 STRAP PRPF19 BOD1L1 SPEN	3.02e-04	1425	103	13	30948266
Pubmed	HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways.	CAD POLR2B TRIP13 RNF126 CDC45 PPP6C ELP2 VCP	3.05e-04	571	103	8	37167062
Pubmed	Obesity and diabetes genes are associated with being born small for gestational age: results from the Auckland Birthweight Collaborative study.	IGF2BP2 KCNJ11 LPL	3.06e-04	44	103	3	20712903
Pubmed	Association study of genetic variants in eight genes/loci with type 2 diabetes in a Han Chinese population.	IGF2BP2 KCNJ11	3.08e-04	9	103	2	20550665
Pubmed	Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk.	IGF2BP2 KCNJ11	3.08e-04	9	103	2	18598350
Pubmed	Beta cell glucose sensitivity is decreased by 39% in non-diabetic individuals carrying multiple diabetes-risk alleles compared with those with no risk alleles.	IGF2BP2 KCNJ11	3.08e-04	9	103	2	18719881
Pubmed	Switching of α-Catenin From Epithelial to Neuronal Type During Lens Epithelial Cell Differentiation.	ANK2 ARVCF	3.08e-04	9	103	2	28692740
Pubmed	FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway.	FAAP100 FANCA	3.08e-04	9	103	2	17396147
Pubmed	Targeted inactivation of the mouse alpha 2-macroglobulin gene.	A2M LPL	3.08e-04	9	103	2	7544347
Pubmed	Yeast two-hybrid screening identified WDR77 as a novel interacting partner of TSC22D2.	FLNB MTIF2 LPL	3.27e-04	45	103	3	27337956
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	ZNF536 POLR2B CHD1 DENND4C MEX3A PPP6C STRAP BOD1L1 AKAP1	3.37e-04	733	103	9	34672954
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	VPS11 CAD NEDD4L RUVBL1 BOD1L1 SPEN	3.48e-04	313	103	6	38270169
Pubmed	ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure.	FLNB POLR2B IGF2BP2 MEX3A STRAP VCP	3.60e-04	315	103	6	26777405
Pubmed	Interleukin-9 polymorphism in infants with respiratory syncytial virus infection: an opposite effect in boys and girls.	PF4 TLR7 IL18R1 C5 CCL24	3.63e-04	204	103	5	20503287
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	FLNB IMPDH1 POLR2B TRIP13 CBS TXNRD1 RUVBL1 PPP6C STRAP PRPF19 ELP2 KIF13A VCP	3.69e-04	1455	103	13	22863883
Pubmed	Genetic susceptibility to respiratory syncytial virus bronchiolitis in preterm children is associated with airway remodeling genes and innate immune genes.	PF4 TLR7 IL18R1 C5 CCL24	3.71e-04	205	103	5	19258923
Pubmed	Type 2 diabetes-associated genetic variants discovered in the recent genome-wide association studies are related to gestational diabetes mellitus in the Korean population.	IGF2BP2 KCNJ11	3.85e-04	10	103	2	19002430
Pubmed	Multiple UBX proteins reduce the ubiquitin threshold of the mammalian p97-UFD1-NPL4 unfoldase.	CDC45 VCP	3.85e-04	10	103	2	35920641
Pubmed	A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants.	IGF2BP2 KCNJ11	3.85e-04	10	103	2	17463248
Pubmed	Atypical chemokine receptor ACKR2 controls branching morphogenesis in the developing mammary gland.	PF4 CCL24	3.85e-04	10	103	2	27888192
Pubmed	Interaction between prenatal growth and high-risk genotypes in the development of type 2 diabetes.	IGF2BP2 KCNJ11	3.85e-04	10	103	2	19225753
Pubmed	Evidence of interaction between type 2 diabetes susceptibility genes and dietary fat intake for adiposity and glucose homeostasis-related phenotypes.	IGF2BP2 KCNJ11	3.85e-04	10	103	2	20215779
Pubmed	Type 2 diabetes susceptibility loci in the Ashkenazi Jewish population.	IGF2BP2 KCNJ11	3.85e-04	10	103	2	18516622
Pubmed	Association between insulin secretion, insulin sensitivity and type 2 diabetes susceptibility variants identified in genome-wide association studies.	IGF2BP2 KCNJ11	3.85e-04	10	103	2	19082521
Pubmed	Combined risk allele score of eight type 2 diabetes genes is associated with reduced first-phase glucose-stimulated insulin secretion during hyperglycemic clamps.	IGF2BP2 KCNJ11	3.85e-04	10	103	2	19808892
Pubmed	Coronary artery calcification and its relationship to validated genetic variants for diabetes mellitus assessed in the Heinz Nixdorf recall cohort.	IGF2BP2 KCNJ11	3.85e-04	10	103	2	20616309
Pubmed	Modularized functions of the Fanconi anemia core complex.	FAAP100 FANCA	3.85e-04	10	103	2	24910428
Pubmed	Genetic predisposition, Western dietary pattern, and the risk of type 2 diabetes in men.	IGF2BP2 KCNJ11	3.85e-04	10	103	2	19279076
Pubmed	Confirmation of multiple risk Loci and genetic impacts by a genome-wide association study of type 2 diabetes in the Japanese population.	IGF2BP2 KCNJ11	3.85e-04	10	103	2	19401414
Pubmed	Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes.	PF4 TLR7 IL18R1 C5 CCL24	3.88e-04	207	103	5	17703412
Pubmed	Identification of DeltaNp63alpha protein interactions by mass spectrometry.	A2M CAD VCP	3.96e-04	48	103	3	20085233
Pubmed	VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway.	CAD TRIP13 TXNRD1 RUVBL1 STRAP VCP	4.53e-04	329	103	6	35562734
Pubmed	Forkhead transcription factor FoxF1 interacts with Fanconi anemia protein complexes to promote DNA damage response.	FAAP100 FANCA	4.69e-04	11	103	2	26625197
Cytoband	Xp11.22	CENPVL2 CENPVL3 CENPVL1	2.50e-04	54	103	3	Xp11.22
GeneFamily	Peptidyl arginine deiminases	PADI4 PADI3	1.55e-04	5	72	2	677
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	A2M C5	5.53e-04	9	72	2	1234
GeneFamily	Ring finger proteins	VPS11 MEX3D RNF126 MEX3C MEX3A RNF38	7.91e-04	275	72	6	58
GeneFamily	AAA ATPases	TRIP13 RUVBL1 VCP	1.23e-03	53	72	3	413
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	PAPPA2 CSMD2 SEZ6L2	1.52e-03	57	72	3	1179
GeneFamily	WD repeat domain containing	WDR88 STRAP PRPF19 ELP2 WDR90	3.91e-03	262	72	5	362
GeneFamily	Selenoproteins	TXNRD1 TXNRD3	4.42e-03	25	72	2	890
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	MRC1 CD163L1	5.15e-03	27	72	2	1253
Coexpression	GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP	CHD1 MLXIP CRY2 RNF38 SPEN ALK TP53BP2	9.14e-06	192	100	7	M8272
ToppCell	severe-unassigned\|severe / disease stage, cell group and cell class	MCM8 IL18R1 F12 ARL17A ZNF18 MEX3A	2.24e-06	165	102	6	f9ddd547992fec065d539a1d0305acba8fc7d79c
ToppCell	facs-Liver-Hepatocytes-24m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PF4 TLR7 LPL DGKI ALOXE3 CCL24	2.48e-06	168	102	6	4ae9e9d93bcd6f4d5815e57fd5afa7a3398a0ec1
ToppCell	facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PF4 TLR7 LPL DGKI ALOXE3 CCL24	2.48e-06	168	102	6	04e168fe1d6f5f9e3d3bf9d7c13e800e3594868a
ToppCell	facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PF4 TLR7 LPL DGKI ALOXE3 CCL24	2.57e-06	169	102	6	454b92b9b67299a64278c010db033ca5b9d217a0
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MCM8 LAMA3 TRIP13 CDC45 FANCA DOT1L	3.58e-06	179	102	6	88d44b04eb5c079531db663ed98ddb20b60feb9a
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF536 FRAS1 RELN LAMA3 ALK UNC5D	4.46e-06	186	102	6	310d16f4e5cffee3ea6d7635508c513a3b92131e
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FRAS1 SFTA3 NEDD4L LAMA3 CELSR1 PTPRQ	4.60e-06	187	102	6	4ae7465174e0295d2c3b614b321a3b2f514dd22a
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FRAS1 SFTA3 NEDD4L LAMA3 PTPRQ C5	5.04e-06	190	102	6	8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF536 FRAS1 RELN LAMA3 ALK UNC5D	5.19e-06	191	102	6	fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF536 RELN LAMA3 SEZ6L2 CD163L1 VWA5B1	5.35e-06	192	102	6	025fac36b862f9ca7f96fb4a1946c44ba7cbc382
ToppCell	Severe_COVID-19-Myeloid-proliferating_Myeloid_cells\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	MCM8 THAP10 CPED1 TRIP13 CDC45 LPL	5.51e-06	193	102	6	0d85025690c9cd545cba30abc38acbdd6a39b153
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNB CAD ANK2 SEZ6L2 DENND4C VCP	5.51e-06	193	102	6	471e65f02937bc18d7c5facdacdf1df58cf0f839
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNB CAD ANK2 SEZ6L2 DENND4C VCP	5.51e-06	193	102	6	fe451b3295d77b2bd1ac25cf29310c85835a45fe
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ZNF536 MCM8 CPED1 TRIP13 CDC45 FANCA	5.51e-06	193	102	6	516ea2c12bdc7a5dc676159d627e36f6abe13ef0
ToppCell	BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MCM8 THAP10 CPED1 TRIP13 CDC45 LPL	5.68e-06	194	102	6	cb39850e9577015b6b9834e98c36b412bae7d462
ToppCell	BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MCM8 THAP10 CPED1 TRIP13 CDC45 LPL	5.68e-06	194	102	6	408597c9aa302a44b112c1d612c21fbb0227a82a
ToppCell	BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MCM8 THAP10 CPED1 TRIP13 CDC45 LPL	5.68e-06	194	102	6	193cc20fefbd795a4ad59e401a95af47d30603e7
ToppCell	BAL-Severe-Myeloid-Myeloid\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MCM8 THAP10 CPED1 TRIP13 CDC45 LPL	5.68e-06	194	102	6	2360b5f995b360419de41612368cab9fb61781a1
ToppCell	BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	MCM8 THAP10 CPED1 TRIP13 CDC45 LPL	5.68e-06	194	102	6	903ae11708b0cb24538c6982abd57fe6fa95b8d3
ToppCell	BAL-Severe-Myeloid-Myeloid\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	MCM8 THAP10 CPED1 TRIP13 CDC45 LPL	5.68e-06	194	102	6	58406502a8cbcc3037f79a1b6a683df408297ae5
ToppCell	10x5'-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages\|GI_small-bowel / Manually curated celltypes from each tissue	A2M MRC1 TLR7 CPED1 CD163L1 CCL24	6.02e-06	196	102	6	075e5746fa5cb121115a1d51b823c0fbf8d54305
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn\|World / Primary Cells by Cluster	NEDD4L ANK2 POLR2B MEX3A GNG3 UNC5D	6.02e-06	196	102	6	9401bd84798f0ea3e986e94135a9e1dc5643330f
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	LAMA3 CSMD2 CELSR1 PTPRQ ALOXE3 C5	6.20e-06	197	102	6	b94645d57efe8d9e032bffb8c89af1f425c6421e
ToppCell	wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-stalk_intermediate\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	FRAS1 SFTA3 NEDD4L LAMA3 CELSR1 C5	6.57e-06	199	102	6	debdd7dba774d9ccff7effc3f4c132393d203dfa
ToppCell	Substantia_nigra-Hematopoietic-MACROPHAGE-MP1(C1qb)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	MRC1 PF4 TLR7 CCL24 PADI3	7.13e-06	116	102	5	e93dd059d272e597a30e93f4c0504636f4e6c899
ToppCell	Substantia_nigra-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	MRC1 PF4 TLR7 CCL24 PADI3	7.13e-06	116	102	5	27201cb805fe73b5ec51d7d585d047a4c043e8b0
ToppCell	Substantia_nigra-Hematopoietic-MACROPHAGE\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	MRC1 PF4 TLR7 CCL24 PADI3	7.13e-06	116	102	5	d3194bda2e3d5fd021e4015eed98c5888befe03d
ToppCell	Substantia_nigra-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	MRC1 PF4 TLR7 CCL24 PADI3	7.13e-06	116	102	5	4e84b6f6661bb5ba0fe0de38a23bee9cc3727d94
ToppCell	Substantia_nigra-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	MRC1 PF4 TLR7 CCL24 PADI3	7.13e-06	116	102	5	15d9a3d8c3cc1f6a1aead03cf84dc876c76b7063
ToppCell	Substantia_nigra-Hematopoietic\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	MRC1 AKNA PF4 TLR7 CCL24	3.37e-05	160	102	5	19d71d02f06f34eff37d268a78e5eed34da4ca44
ToppCell	PND07-28-samps-Myeloid-Macrophage-macrophage-C\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	PIWIL2 IGF2BP2 KCNJ11 LPL	3.45e-05	80	102	4	3413ac5e1c1e59eab6a83b889b870a8db4efccb9
ToppCell	droplet-Fat-Mat-18m-Myeloid-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC1 PF4 CASR TLR7 CCL24	3.47e-05	161	102	5	8c62ae3fcf304db0f71633e328ceba81a70f03c4
ToppCell	droplet-Marrow-nan-21m-Lymphocytic-plasma_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC1 RALGDS TLR7 LPL CCL24	4.02e-05	166	102	5	91eeb48680dd07ae4115afacdc0a8f6fa18885e5
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA3 TRIP13 CDC45 FANCA C5	4.37e-05	169	102	5	121768fc51fc3441ec725346a1bbe29e21d05971
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CASR SEZ6L2 KCNJ11 MADCAM1 UNC5D	4.50e-05	170	102	5	941d637cf76918ee4b0a1833abd1a42593cb8b1a
ToppCell	droplet-Trachea-3m-Hematologic-myeloid-granulocyte-\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MRC1 MCM8 PF4 CDC45 CCL24	4.63e-05	171	102	5	41932c9e70829ee3d55ca5fdb74d290fc8229416
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Lymphocytic-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF536 IL18R1 MEX3A CD163L1 MADCAM1	5.02e-05	174	102	5	6987fe7959afce347282f632abc16d800ccab7c4
ToppCell	facs-Marrow-B-cells-18m-Hematologic-hematopoietic_stem_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN CPED1 CD163L1 KCNJ11 GNG3	5.45e-05	177	102	5	35d42b07d9c31528bf59199e361bb8a3bfbe3b75
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FRAS1 SFTA3 NEDD4L PTPRQ C5	5.45e-05	177	102	5	75cb2067a3f2d1b5a964890b02b604d1e79bd163
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF536 RELN LAMA3 SEZ6L2 VWA5B1	5.75e-05	179	102	5	cd7f0e8f4abb2a2bac366c8910c8c5fda841dbce
ToppCell	5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NEDD4L ANK2 CSMD2 DGKI ALK	6.06e-05	181	102	5	40df0afcb6848202da54670e84f22d7c3a515d01
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF536 FRAS1 LAMA3 SEZ6L2 VWA5B1	6.06e-05	181	102	5	6c55985e464cb0f5fb3362e9fd90351b671950f7
ToppCell	5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NEDD4L ANK2 CSMD2 DGKI ALK	6.06e-05	181	102	5	2b53a65ca5616a7b9f64232c3e0b7212d1e2f063
ToppCell	5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NEDD4L ANK2 CSMD2 DGKI ALK	6.06e-05	181	102	5	6aef84616e8d2faf54b7e9e6cd02f33c3066dabc
ToppCell	5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NEDD4L ANK2 CSMD2 DGKI ALK	6.06e-05	181	102	5	40d3829ae4aaf81e8616c3499ff8933137fc1cc4
ToppCell	Control-Epithelial-Basal\|World / Disease state, Lineage and Cell class	SFTA3 NEDD4L LAMA3 CELSR1 PTPRQ	6.22e-05	182	102	5	759390dde9b18757f7675d13d44c89d0e32f8d93
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FRAS1 LAMA3 CPED1 IL18R1 TP53BP2	6.22e-05	182	102	5	573771130247e869e4e58f22d4a1cb31989635cf
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FRAS1 LAMA3 CPED1 IL18R1 TP53BP2	6.22e-05	182	102	5	6cfaa2b3b3974c13b01c943f4adb70768dcc35e4
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	A2M FLNB LAMA3 CPED1 KIF13A	6.38e-05	183	102	5	818fd886e0188091310825f9145fa53328f2c979
ToppCell	Striatum-Macroglia-POLYDENDROCYTE-P5\|Striatum / BrainAtlas - Mouse McCarroll V32	ANKLE1 TRIP13 CDC45 FANCA MEX3A	6.38e-05	183	102	5	f20b0d71f857ac35868fd80531050ad8b6091716
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	IQCN DENND4C MLYCD FANCA MTIF2	6.38e-05	183	102	5	fef51dcf180e6d4e136362c7e140ec5ef372e6d0
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M FRAS1 RELN PTPRQ UNC5D	6.55e-05	184	102	5	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	PCW_13-14-Neuronal\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	RELN CSMD2 CENPVL3 GNG3 ALK	6.55e-05	184	102	5	65cf3460125e3dbc34978957bc138a449f71f7df
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M FRAS1 RELN PTPRQ UNC5D	6.55e-05	184	102	5	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M FRAS1 RELN PTPRQ UNC5D	6.55e-05	184	102	5	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF536 AOC1 LAMA3 SEZ6L2 IL18R1	6.72e-05	185	102	5	caf4f57f2db9ff72a652c8573e16e7ab180ffc05
ToppCell	Epithelial-alveolar_epithelial_cell_type_1\|World / Lineage, Cell type, age group and donor	SFTA3 NEDD4L LAMA3 CELSR1 PTPRQ	6.89e-05	186	102	5	09d95daa3387a4814cffaa4b798cc2810c3759d0
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF536 RELN LAMA3 SEZ6L2 VWA5B1	7.07e-05	187	102	5	eb011a3d8a3025cebb0fba36d403be906305372c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PAPPA2 FLNB CASR IGF2BP2 DOT1L	7.07e-05	187	102	5	f124d2c699b717b7c02a1a70493f515b83dc2f4c
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SFTA3 NEDD4L LAMA3 CELSR1 PTPRQ	7.25e-05	188	102	5	eea652bab161f19148a883e7e3fe2523b36b3cea
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZNF536 BEND5 CPED1 RNF38 KIF13A	7.25e-05	188	102	5	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF536 FRAS1 RELN LAMA3 ALK	7.25e-05	188	102	5	0501a8aa850bd2e347020abd1cac4d8075738189
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZNF536 BEND5 CPED1 RNF38 KIF13A	7.25e-05	188	102	5	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	A2M FLNB LAMA3 CPED1 KIF13A	7.25e-05	188	102	5	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZNF536 BEND5 CPED1 RNF38 KIF13A	7.25e-05	188	102	5	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	droplet-Heart-nan-18m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF536 RELN FAAP100 MEX3A ARVCF	7.43e-05	189	102	5	0493f7b79127c207fd7ade778ef4810500495d7e
ToppCell	3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ANK2 FOXN4 F12 CENPVL3 GNG3	7.62e-05	190	102	5	bdbfaced785db79ff965f332759be258dbf743cf
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-VLMC-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PAPPA2 SFTA3 NEDD4L CELSR1 CNGB3	7.62e-05	190	102	5	c90410bb47b8da774dee2a3502f667ce9a7c97d9
ToppCell	droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MRC1 RELN ANK2 DUOX2 CELSR1	7.62e-05	190	102	5	f50b9814a1beac67dc042a8c27dfd085ceeda3a6
ToppCell	facs-Lung-3m-Endothelial-lymphatic_endothelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MRC1 RELN ANK2 DUOX2 CELSR1	7.62e-05	190	102	5	a1514d2186eb4fe569971ab22dc0c17d353fb94a
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-VLMC\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PAPPA2 SFTA3 NEDD4L CELSR1 CNGB3	7.62e-05	190	102	5	bc44727e8458a02fae95dc5515b708000d2ee8c4
ToppCell	droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MRC1 RELN ANK2 DUOX2 CELSR1	7.62e-05	190	102	5	a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c
ToppCell	facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MRC1 RELN ANK2 DUOX2 CELSR1	7.62e-05	190	102	5	0bb954a94317cfc742b9b6221bb80f8baa6d3ff1
ToppCell	droplet-Lung-21m-Endothelial-lymphatic_endothelial\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MRC1 RELN ANK2 DUOX2 CELSR1	7.62e-05	190	102	5	57c136bf6d7feafb4a220877bed0cc8fdf314db2
ToppCell	facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MRC1 RELN ANK2 DUOX2 CELSR1	7.62e-05	190	102	5	26e2237f65cb43723c5da853831b40df2982d6e4
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MCM8 ANKLE1 TRIP13 CDC45 DGKI	7.81e-05	191	102	5	15dbc5a03bfab8931c0fd385b0f25874736ae874
ToppCell	facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC1 RELN ANK2 DUOX2 CELSR1	7.81e-05	191	102	5	48823a97c38263f2c6e58348214f5b62773a6368
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF536 FRAS1 RELN LAMA3 ALK	7.81e-05	191	102	5	7b386512284dfaa0e95358b28ee82632ee965e64
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF536 RELN LAMA3 SEZ6L2 VWA5B1	7.81e-05	191	102	5	06760c3bb40e4f66879a5f5e09c9abfce4ebbba3
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MCM8 ANKLE1 TRIP13 CDC45 DGKI	7.81e-05	191	102	5	45c15f5ce4a207ac944bed65d45f06c1657d1a6d
ToppCell	facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC1 RELN ANK2 DUOX2 CELSR1	7.81e-05	191	102	5	0eedc66e967b1837ce2c14f8c14b3c1eba868c76
ToppCell	wk_08-11-Epithelial-PNS-KCNIP4+_neuron\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	ANK2 F12 DGKI GNG3 ALK	8.00e-05	192	102	5	53642c88891f4e4e14b1740c5ced759b7d8b3572
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF536 RELN LAMA3 SEZ6L2 CD163L1	8.00e-05	192	102	5	6a252e298f8a454623fa9c1c893a7a45a886d694
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ANKLE1 TRIP13 FANCA WDR90 C5	8.00e-05	192	102	5	d6f656be2698bd215717d35f4e7ab727c08c61e0
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FRAS1 DUOX2 CNGB3 PTPRQ VWA5B1	8.20e-05	193	102	5	315840bc48899f3a36d57b19197509de19716e3d
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF536 SFTA3 RELN ALK UNC5D	8.20e-05	193	102	5	294cb5b580bb83fe0eb04f112d5507aac35d4d44
ToppCell	5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF536 ANK2 FOXN4 LPL ALK	8.20e-05	193	102	5	4f4f430d7e1b65e19ca829f55ca93edeb6c1c85d
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ZNF536 MCM8 TRIP13 CDC45 FANCA	8.20e-05	193	102	5	bbdfda6665941cfa1965418bb91ef9ff43b1326f
ToppCell	3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ANK2 FOXN4 F12 CENPVL3 GNG3	8.20e-05	193	102	5	8851275bcf4ecd6e87a91c8784fc5d76d246ff3b
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF536 SFTA3 RELN ALK UNC5D	8.20e-05	193	102	5	3d3c45d5ff6f3396a1990615aae9fe176e799994
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF536 SFTA3 RELN ALK UNC5D	8.40e-05	194	102	5	52aebb0b563e2c2058e7f0554ae870e47692b163
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ZNF536 MCM8 TRIP13 CDC45 FANCA	8.40e-05	194	102	5	590a9d4f054e6a3685daf752c9354650fcc7d18a
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF536 SFTA3 RELN ALK UNC5D	8.40e-05	194	102	5	bd06e2b8d8c06cddf2e4f58849b86e09013acae1
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CAD ANK2 SEZ6L2 DENND4C VCP	8.40e-05	194	102	5	0b023de48ed8a550d169bbe954881eb04bf4f981
ToppCell	356C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)\|356C / Donor, Lineage, Cell class and subclass (all cells)	A2M MRC1 TLR7 CPED1 CD163L1	8.61e-05	195	102	5	9231e929657542b78a6480d44402866511129c7f
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	LAMA3 CELSR1 C5 AKAP1 TP53BP2	9.03e-05	197	102	5	1485933986921ff45669d9b7501c8d17050b3e97
ToppCell	5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ANK2 F12 CENPVL3 GNG3 ALK	9.03e-05	197	102	5	a1ae1aa797762a3768e14434c7e5cd19c595ecb3
ToppCell	COVID-19-COVID-19_Convalescent-Others-HSPC\|COVID-19_Convalescent / Disease, condition lineage and cell class	PGBD1 CPED1 IGF2BP2 MEX3A TXNRD3	9.03e-05	197	102	5	c1033a1a8b8b5c8569130aa9405a6e8e65ef7bd0
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FLNB FRAS1 SFTA3 NEDD4L CELSR1	9.25e-05	198	102	5	af399569c718f5fd971d73a7926768c9311002a3
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	LAMA3 CELSR1 C5 AKAP1 TP53BP2	9.25e-05	198	102	5	285f729140b1df029c24f6ca1d2438470ac51794
Drug	N-Ni	CBS PRUNE1 CBLIF	1.63e-06	6	100	3	CID005278690
Disease	3-methoxytyrosine measurement	DENND4C ARVCF UNC5D	1.07e-04	27	101	3	EFO_0021009
Disease	level of lipoprotein lipase in blood serum	F12 LPL	1.15e-04	5	101	2	OBA_2042223
Disease	nitric oxide exhalation measurement	PAPPA2 ZNF536 ANK2	3.01e-04	38	101	3	EFO_0005536
Disease	alpha-2-macroglobulin measurement	A2M F12	3.20e-04	8	101	2	EFO_0020138
Disease	Hypertensive disease	AOC1 NEDD4L CBS F12 LPL	5.05e-04	190	101	5	C0020538
Disease	hyperhomocysteinemia (implicated_via_orthology)	CBS F12	6.25e-04	11	101	2	DOID:9279 (implicated_via_orthology)
Disease	phenylalanine measurement	F12 TXNRD1 KIF13A	8.97e-04	55	101	3	EFO_0005001
Disease	Schizophrenia	RELN PGBD1 CSMD2 IL18R1 CBS CBLIF IGF2BP2 ARVCF LPL ALK	9.03e-04	883	101	10	C0036341
Disease	hippocampus volume change measurement	RELN ERI3	1.18e-03	15	101	2	EFO_0021492
Disease	aspartate aminotransferase to alanine aminotransferase ratio	MRC1 NEDD4L AKNA MLXIP MLYCD	1.41e-03	239	101	5	EFO_0010934
Disease	Mental Depression	A2M RELN CSMD2 CRY2 ALK	1.84e-03	254	101	5	C0011570
Disease	ovulation	MCM8 FANCA	1.91e-03	19	101	2	GO_0030728
Disease	freckles	FANCA AKAP1	2.12e-03	20	101	2	EFO_0003963
Disease	nicotine dependence symptom count, depressive symptom measurement	AOC1 CPED1 IGF2BP2	2.20e-03	75	101	3	EFO_0007006, EFO_0009262
Disease	intellectual disability (implicated_via_orthology)	ANK2 BOD1L1 ELP2	2.20e-03	75	101	3	DOID:1059 (implicated_via_orthology)
Disease	COVID-19 (is_implicated_in)	A2M TLR7	2.33e-03	21	101	2	DOID:0080600 (is_implicated_in)
Disease	Depressive disorder	A2M RELN CSMD2 CRY2 ALK	3.21e-03	289	101	5	C0011581

Protein segments in the cluster

Peptide	Gene	Start	Entry
GHSTCPEEVFVEASP	BEND5	151	Q7L4P6
VVHPQLTPFCTELTG	ERI3	191	O43414
EESCVPVHQKTVLGP	AKAP1	386	Q92667
VCAHHIIPTGSVVIP	CCL24	16	O00175
GPCRHLPVSTVSDLE	ANKLE1	351	Q8NAG6
VEEDPGTPTSHVSIV	ARVCF	96	O00192
VTCPDVSSISVEHGR	CSMD2	2591	Q7Z408
IHPEETCGLQPISSD	CPED1	691	A4D0V7
CSEHIPSTIAVVGAT	CASR	131	P41180
ETVPAVPTVGFCVET	ARL17A	41	Q8IVW1
VAPHCLDEGTVRSVV	CENPVL1	221	A0A0U1RR11
TGVIGCIPAHDPDVS	CELSR1	1121	Q9NYQ6
SPLDQEVVPCTPSHV	DOT1L	741	Q8TEK3
VTHELAPGIDCPETA	AOC1	381	P19801
APPCIHGNTVSVICT	CD163L1	986	Q9NR16
VSDAPVHITASGEPV	CHD1	1386	O14646
HFTEVPVTPETICRD	TP53BP2	16	Q13625
ELCGTEVPSVPEHGR	A2M	881	P01023
GQPITDITTCLIPAH	IQCN	746	Q9H0B3
CDHPPIVSEEDISVG	ANK2	3706	Q01484
PEQPTHAVCVLGTLT	PADI4	11	Q9UM07
PPCHVSVELVGSCAT	PRUNE1	136	Q86TP1
SCTSRPHITVVEGEP	IL18R1	21	Q13478
VTIGTDSAICHTPVV	FRAS1	3291	Q86XX4
VPGDPEVACTAHKVT	MADCAM1	126	Q13477
TCVSLAHETPPTALI	LAMA3	1066	Q16787
VHDLVDSCVPGDTVT	MCM8	316	Q9UJA3
SSRLPCAVEEHPVGE	MTIF2	611	P46199
RICVTEPDGSVSHFP	ALOXE3	86	Q9BYJ1
TSPGVTLQPCHVEEL	GDF1	81	P27539
SPPCRHHVPSDTEVI	LMLN	61	Q96KR4
TGPASECELLDPHVA	KCNG4	481	Q8TDN1
SHCSTPGEPLVVLHV	MLYCD	241	O95822
HVLSDVVSVETPGCP	DUOX2	111	Q9NRD8
APSEGTAEPCVTSIH	KCNJ11	101	Q14654
PSGAVEECHVSELEP	FLNB	2326	O75369
LIGVHGPTTPCEEVS	FLNB	2546	O75369
PEDTAEDTCHLIPGV	LPL	46	P06858
ECVPVPSSEHVAEIV	MEX3D	181	Q86XN8
DAHACEDPLITPVPT	GNG3	46	P63215
VGEEEFVCEPPVVTH	LRFN3	286	Q9BTN0
PVTIHATPEGTSEAC	IGF2BP2	241	Q9Y6M1
THTQLTGTIATPPVC	PRDM10	821	Q9NQV6
LEHPTSAVCVAGVET	PADI3	11	Q9ULW8
VLCSVSPSGSRVPHD	FAAP100	196	Q0VG06
LVTEECVPPTIGCLH	RELN	1696	P78509
TDPVVLSPSHTVGDV	IMPDH1	116	P20839
TCHVSTLPETVPSVP	PTPRQ	1461	Q9UMZ3
ALPCVAESPTVHVEV	TRIP13	11	Q15645
SISNEVPEHPCVSPV	PRPF19	6	Q9UMS4
PVCHFVTPLDGSVDV	MLXIP	181	Q9HAP2
PVSLVTGEPHSLICT	PAPPA2	1206	Q9BXP8
LVSGEVPECEVAHTS	BOD1L1	2011	Q8NFC6
HGTVTVVGIPPETDS	CDC45	501	O75419
VTCSPDHEVQPTLPS	CBLIF	286	P27352
VAPHCLDEGTVRSVV	CENPVL2	221	P0DPI3
SVPSCVEDLSHPVAE	CRY2	521	Q49AN0
EEPCSLGAHAAVIVP	DGKI	306	O75912
VGQICTAPAETSHPV	FANCA	121	O15360
AVEGICTSESPVIDH	C5	861	P01031
VAPHCLDEGTVRSVV	CENPVL3	221	A0A0U1RRI6
TCPVHESPSGIDTSE	GON4L	2091	Q3T8J9
APLTVLPTITCGHTI	CBS	421	P35520
CVIVTSKGETPPHTF	DENND4C	161	Q5VZ89
ASTGPCPLHVNVEVS	AKNA	716	Q7Z591
EVGVPDSCPVVLHSF	RALGDS	36	Q12967
GAVTAVSVCPVLHPS	ELP2	721	Q6IA86
VEPTHSSPEGSCREV	FAM90A20P	226	A6NIJ5
PCSPTGQTHGEEDVV	KIF28P	676	B7ZC32
VIPSESDVPTHCPSQ	MRC1	351	P22897
EGCTSETPHALTVSP	KIF13A	1441	Q9H1H9
HTVVLTVTGEPCHFP	F12	36	P00748
GEPEAPVLTHATTVA	FOXN4	321	Q96NZ1
TVTTVAPHGIPLCTG	RNF38	201	Q9H0F5
PTPGTVVDHTITSCE	PIWIL2	871	Q8TC59
NTTECVPVPSSEHVA	MEX3C	231	Q5U5Q3
VPVTEEHVGSGLECP	RNF126	216	Q9BV68
FTCEGITPDIIINPH	POLR2B	956	P30876
IGEVTITCVPGHPSQ	SEZ6L2	806	Q6UXD5
IPCSTPIATERTVAH	PGBD1	296	Q96JS3
TPLTCSGHTRPVVDL	STRAP	6	Q9Y3F4
EDGVSCIVSPTPEPH	ALK	1016	Q9UM73
CTASPIAVEEEPHSV	CNGB3	756	Q9NQW8
DSTIGIHPVCAEVFT	TXNRD1	616	Q16881
EHEGPVSSVCVSPDG	WDR90	656	Q96KV7
PGTEPTVVSCLTVHE	VPS11	136	Q9H270
EHRPKAPVVECSITG	WDR88	141	Q6ZMY6
TAIAEPVSAAPCLHE	SPEN	2556	Q96T58
VAPDTVIHCEGEPIK	VCP	176	P55072
VQPVSTPVTVCGDIH	PPP6C	41	O00743
NTTECVPVPTSEHVA	MEX3A	131	A1L020
SPHVSEKSEGPCVRV	FAM90A2P	426	Q658T7
IVTTPFALTIPHCAD	UNC5D	611	Q6UXZ4
CTDKHLTEIPGGIPT	TLR7	51	Q9NYK1
TSLEVIKAGPHCPTA	PF4	56	P02776
IHVAALVVGECCPTP	CAD	81	P27708
CVIRGTEDITSPHGI	RUVBL1	336	Q9Y265
LCLGVSSAEPEAEPH	ZNF536	6	O15090
DTIGIHPTCGEVFTT	TXNRD3	611	Q86VQ6
CVAVCVPSPGTVHTA	SFTA3	56	P0C7M3
SPSCQVGEVEPHLEV	ZNF18	146	P17022
SNTVTSVPTHCEEGP	THAP10	161	Q9P2Z0
STVERHCGKIPAPVS	UGT2A2	186	P0DTE5
GPCLLAGVESPTHEI	VWA5B1	231	Q5TIE3
CSVTDAVAEQGHLPP	NEDD4L	341	Q96PU5